Research in rats has shown that administering GLP-1 receptor (GLP-1R) agonists to the hippocampus can prevent spatial learning and memory impairments caused by amyloid β (Aβ), a protein implicated in AD [42]. The gene discussed is GLP1R; the disease is Alzheimer disease.